摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(-)-1D-1,4,5-tris-O-allyl-2,3,6-tris-O-benzyl-myo-inositol | 98925-54-3

中文名称
——
中文别名
——
英文名称
(-)-1D-1,4,5-tris-O-allyl-2,3,6-tris-O-benzyl-myo-inositol
英文别名
(+)-1,3,4-tri-O-allyl-2,5,6-tri-O-benzyl-myo-inositol;(±)-2,3,6-tri-O-benzyl-1,4,5-tri-O-allyl-myo-inositol;(+/-)-1,4,5-tri-O-allyl-2,3,6-tri-O-benzyl-myo-inositol;1,4,5-tri-O-allyl-2,3,6-tri-O-benzyl-myo-inositol
(-)-1D-1,4,5-tris-O-allyl-2,3,6-tris-O-benzyl-myo-inositol化学式
CAS
98925-54-3;104873-75-8;111466-06-9;114418-97-2;140148-52-3
化学式
C36H42O6
mdl
——
分子量
570.726
InChiKey
ODPDGVXEMDSAFL-KPTSLFCISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.47
  • 重原子数:
    42.0
  • 可旋转键数:
    18.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    55.38
  • 氢给体数:
    0.0
  • 氢受体数:
    6.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • The preparation of racemic and enantiomerically pure myo-inositol derivatives as intermediates for the synthesis of phosphatidylinositol 3-, 3,4-bis-, and 3,4,5-tris-phosphates and for the synthesis of analogues of 1d-myo-inositol 1,3,4,5-tetrakisphosphate
    作者:Trupti Desai、Jill Gigg、Roy Gigg、Eloisa Martín-Zamora
    DOI:10.1016/s0008-6215(96)00211-x
    日期:1996.12
    1,5,6-tris(dibenzyl phosphate) and (±)-2,4-di-O-benzyl-1,5,6-tri-O-p-methoxybenzyl-myo-inositol (intermediates for phosphatidylinositol 3,4,5-trisphosphate). Some of the intermediates used in the above preparations were also used for the synthesis of myo-inositol derivatives suitable for the preparation of analogues of 1d-myo-inositol 1,3,4,5-tetrakisphosphate. Thus 1l-2,4-di-O-benzyl-5-O-p-methoxybenzyl-myo-inositol
    摘要这里提供了先前在初步通报中描述的通过1,2-O-异亚丙基-肌醇的介导的丙基化和苄基化反应获得的产品的详细信息。这些反应的一些产物,特别是3,4,6-三-O-丙基-和3,5,6-三-O-丙基-1,2-O-异亚丙基-肌醇,已被用于制备中间体,用于合成标题化合物。描述了以下化合物的合成:1l-2,4,5,6-四-O-苄基-1-Op-甲苄基-肌醇(磷脂酰肌醇3-磷酸中间体),1l-2,4,5 -三-O-苄基-肌醇1,6-双(磷酸二苄酯)和1l-2,4,5-三-O-苄基-1,6-二-Op-甲苄基-肌醇(中间体磷脂酰肌醇3,4-二磷酸),1l-2,4-二-O-苄基-肌醇1,5,6-三(磷酸苄基)和(±)-2,4-二-O-苄基-1 ,5,6-三-对-甲苄基-肌醇(磷脂酰肌醇3,4,5-三磷酸酯中间体)。在上述制剂中使用的一些中间体也用于合成肌醇衍生物,其适合于制备1d-肌醇1
  • Synthesis and in vitro anticancer activity evaluation of novel bioreversible phosphate inositol derivatives
    作者:Wenbin Chen、Zhaohui Deng、Kuangyu Chen、Daolei Dou、Fanbo Song、Luyuan Li、Zhen Xi
    DOI:10.1016/j.ejmech.2015.01.064
    日期:2015.3
    The chemistry and biology of phosphorylated inositols have become intense areas of research during the last two decades due to their involvement in various cellular signaling processes. However, the metabolic instability by phosphatases or kinases and poor penetration make it difficult to become a drug used in the clinic. The bioreversible protection technique can enhance membrane penetration characteristics and increase the stability of phosphorylated inositols against enzymatic degradation and is applied widely in drug discovery and development. In this paper, we described the design and synthesis of 22 bioreversible phosphotriester inositols, along with the initial antitumor activity results. Most compounds exhibited significant cytotoxic activity against human cancer cell lines A549, MDA-MB-231 and HeLa, but lower cellular toxicity on normal cell MCF10A in comparison with Cisplatin. These compounds can be used as probes to study the mechanism of intracellular signal transduction mediated by phosphate inositol or as leads of phosphate inositol drugs in the clinic. (C) 2015 Elsevier Masson SAS. All rights reserved.
  • Synthesis of (±)-1,2,4-tri-O-benzyl-myo-inositol
    作者:Jill Gigg、Roy Gigg、Sheila Payne、Robert Conant
    DOI:10.1016/0008-6215(85)85064-3
    日期:1985.7
  • The alkylation of dibutylstannylene derivatives of 1,2-O-isopropylidene-myo-inositol.
    作者:Jill Gigg、Roy Gigg、Eloisa Martin-Zamora
    DOI:10.1016/s0040-4039(00)73573-8
    日期:1993.4
    Benzylation (or allylation) of 1,2-O-isopropylidene-myo-inositol in the presence of an excess of dibutyltin oxide gives, as major products, the readily isolable 3,4,6- (12) and 3,5,6-tri-O-alkyl (13) derivatives which are valuable intermediates for the synthesis of inositol phosphates of the phosphatidylinositol cycle.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫